Skip to main content
Have a personal or library account? Click to login
Influence of Beta-Endorphin on Oxygen Activity of Neutrophils and Total Antioxidant Status in Rats after Chronic Administration of Methimazole Cover

Influence of Beta-Endorphin on Oxygen Activity of Neutrophils and Total Antioxidant Status in Rats after Chronic Administration of Methimazole

Open Access
|Mar 2013

References

  1. 1. Bartosz G.: Second face of oxygen. Edited by PWN, Warszawa, 2004.
  2. 2. Bhargava H.N., Ramarao P., Gulati A.: Effect of methimazole-induced hypothyroidism on multiple opioid receptors in rat brain regions. Pharmacology 1988,, 356-364.
  3. 3. Blumberg P.M.: Protein kinase C as the receptor for phorbol esters tumor promoters. Cancer Res 1988,, 1−8.
  4. 4. Cano-Europa E., Blas-Valdivia V., Lopez-Galindo G.E., Franco-Colin M., Pineda-Reynoso M., Hernandez-Garcia A., Ortiz-Butron R.: Methimazole-induced hypothyroidism causes alteration of the REDOX environment, oxidative stress, and hepatic damage; events not caused by hypothyroidism itself. Ann Hepatol 2010,, 80-88.
  5. 5. Cheng M.C., Smith A.I., Funder J.W.: Beta-endorphin and its congeners in rat pituitary and thyroid: effects of propylthiouracil and thyroid hormone administration. Endocrinology 1986,, 642-647.
  6. 6. Cooper D.S.: Antithyroid drugs for the treatment of hyperthyroidism caused by Graves’ disease. Endocrinol Metab Clin North Am 1998,, 225-247.
  7. 7. Das K., Chainy G.B.N.: Modulation of rat liver mitochondrial antioxidant defence system by thyroid hormone. Biochim Biophys Acta 2001,, 1-13.
  8. 8. Das K., Chainy G.B.N.: Thyroid hormone influences antioxidant defense system in adult rat brain. Neurochem Res 2004,, 1755-1766.
  9. 9. Dröge W.: Free radicals in the physiological control of cell function. Physiol Rev 2002,, 47-95.
  10. 10. Ferreira A.C., de Carvalho Cardoso L., Rosenthal D., de Carvalho D.P.: Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole. Eur J Biochem 2003,, 2363-2368.
  11. 11. Glatstein M.M., Garcia-Bournissen F., Giglio N., Finkelstein Y., Koren G.: Pharmacologic treatment of hyperthyroidism during lactation. Can Fam Physician 2009,, 797-798.
  12. 12. Hill K.E., Gieseg M.A., Kingsbury D., Lopez-Villalobos N., Bridges J., Chambers P.: The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism. J Vet Intern Med 2011,, 1357-1365.
  13. 13. Hoffmann G., Marks S.L., Taboada J., Hosgood G.L., Wolfsheimer K.J.: Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg 2003,, 77-82.
  14. 14. Hulbert A.J.: Thyroid hormones and their effects: a new perspective. Biol Rev Cambridge Philos Soc 2000,, 519-621.
  15. 15. Humar M., Dohrmann H., Stein P., Andriopoulos N., Goebel U., Roesslein M.: Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha. J Pharmacol Exp Ther 2008,, 1037-1044.
  16. 16. Ís¸man Ç.A., Yeg˘en B.Ç., Alican Í.: Methimazoleinduced hypothyroidism in rats ameliorates oxidative injury in experimental colitis. J Endocrinol 2003,, 471-476.
  17. 17. Jakóbisiak M. Immunology. Edited by PWN, Warszawa, 1995.
  18. 18. Lécuyer M., Prini S., Dunn M.E., Doucet M.Y.: Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism. Can Vet J 2006,, 131-135.
  19. 19. Marlin D.J., Fenn K., Smith N., Deaton C.D., Roberts C.A., Harris P.A., Dunster C., Kelly F.J.: Changes in circulatory antioxidant status in horses during prolonged exercise. J Nutr 2002,, 1622-1627.
  20. 20. Meier C.A., Fabbro D., Meyhack I., Hemmings B., Olbrecht U., Jakob A., Walter P.: Effect of hypothyroidism and thyroid hormone replacement on the level of protein kinase C and protein kinase A in rat liver. FEBS Lett 1991,, 397-400.
  21. 21. Menzebach A., Hirsch J., Hempelmann G., Welters I.D.: Effects of endogenous and synthetic opioid peptides on neutrophil function. Brit J Anaesth 2003,, 546-550.
  22. 22. Nishiki K., Ericinska M., Wilson D.F., Cooper S.: Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid and hyperthyroid rats. Am J Physiol 1978,, 212-219.
  23. 23. Paller M.S.: Hypothyroidism protects against free radical damage in ischemic acute renal failure. Kidn Int 1986,, 1162-1166.
  24. 24. Peterson M.E., Aucoin D.P.: Comparison of the disposition of carbimazole and methimazole in clinically normal cats. Res Vet Sci 1993,, 351-355.
  25. 25. Peterson M.E., Kintzer P.P., Hurvitz A.I.: Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 1988,, 150-157.
  26. 26. Petrulea M.S., Duncea I., Hazi G., Dragotoiu G., Decea N., Mureşan A.: Oxidative stress in experimental hypothyroidism: effect of vitamin E supplementation. Clujul Medical 2010,245-249.
  27. 27. Regelmann M.O., Miloh T., Arnon R., Morotti R., Kerkar N., Rapaport R.: Graves disease presenting with severe cholestasis. Thyroid 2012,, 437-439.
  28. 28. Rook G.A.W., Steele J., Umar S., Deckrell H.M.: A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by interferon. J Immun Methods 1985,, 161-167.
  29. 29. Rosen H., Klebanoff S.J.: Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system. J Biol Chem 1977,, 4803-4810.
  30. 30. Sarandöl E., Tas S., Dirican M., Serdar Z.: Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct 2005,, 1-8.
  31. 31. Schlaifer D., Cooper M.R., Attal M., Rousseau A., Pris J., Laurent G., Myers C.E.: Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids. Leukemia 1994,, 668-671.
  32. 32. Sewerynek J., Wiktorska J., Nowak D., Lewinski A.: Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. Endocr Regul 2000,, 83-89.
  33. 33. Sharp B.M., Keane W.F., Suh H.J., Gekker G., Tsukayama D., Peterson P.K.: Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 1985,, 793-795.
  34. 34. Sulowska Z., Majewska E., Krawczyk K., Klink M., Tchórzewski H.: Influence of opioid peptides on human neutrophil apoptosis and activation. Mediat Inflamm 2002,, 245-250.
  35. 35. Swaroo A., Ramasarma T.: Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. Bioch J 1985,, 403-408.
  36. 36. Trepanier L.A.: Pharmacologic management of feline hyperthyroidism. Vet Clin North Am Small Anim Pract 2007,, 775-788.
  37. 37. Vail D.M., Elfarra A.A., Panciera D.L., Hutson P.R.: Pharmacokinetics and short-term clinicopathologic changes after intravenous administration of a high dose of methimazole in dogs. Am J Vet Res 1994,, 1597-1601.
  38. 38. Weetman A.P., Holt M.E., Campbell A.K., Hall R., Mc- Gregor A.M.: Methimazole and generation of oxygen radicals by monocytes: Potential role in immunosuppression. Br Med J 1984,, 518-520.
  39. 39. Yang M., Qu H., Deng H.C.: Acute pancreatitis induced by methimazole in a patient with Graves' disease. Thyroid 2012,, 94-96.
  40. 40. Ziegler D.M.: Flavin-containing monooxygenases: enzymes adapted for multisubstrate specificity. Trends Pharmacol Sci 1990,, 321-324.
DOI: https://doi.org/10.2478/bvip-2013-0018 | Journal eISSN: 2450-8608 (formerly 2300-3235)
Language: English
Page range: 97 - 101
Published on: Mar 15, 2013
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services

© 2013 Marcin Gołyński, Krzysztof Lutnicki, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.